Adam C. Ehrlich, MD, MPH, Interim Chief of the Section of Gastroenterology and Hepatology at the Lewis Katz School of Medicine at Temple University and Medical Director of the Inflammatory Bowel Disease (IBD) Program at Temple University Hospital, provided perspective to HealthCentral on a new Gastroenterology paper that makes the case for de-intensifying therapy for people with IBD.
IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH